CTN investigators presenting their work at the XX International AIDS Conference (AIDS 2014, July 20-25) in Melbourne, Australia include Dr. Jean-Pierre Routy, Dr. Marina Klein for the CANOC collaboration study, and reseachers from the CHIWOS study.
Monday July 21, 2014 |
MOPE018 – Poster Exhibition |
A longitudinal assessment of host immunosuppressive responses in primary and chronic HIV infection |
| http://pag.aids2014.org/abstracts.aspx?aid=5782 |
| M.-A. Jenabian1, K. Vyboh1, I. Kema2, C. Kanagaratham3, D. Radzioch3, O. Allam4, A. Ahmad4, N. Gilmore1, P. Ancuta4, C. Tremblay4, J.-P. Routy1, Canadian Primary HIV Infection Study Group |
| 1Chronic Viral Illnesses Service of the McGill University Health Centre, Montreal, Canada, 2University Medical Center, Department of Laboratory Medicine, Groningen, Netherlands, 3Research Institute of the McGill University Health Centre, Montreal, Canada, 4University of Montreal, Department of Microbiology and Immunology, Montreal, Canada |
MOPE081 – Poster Exhibition |
Transition needs of children and youth living with HIV in Vietnam |
| http://pag.aids2014.org/abstracts.aspx?aid=1175 |
| H.T. Huyen1, J. Brophy2,3,4, N. Huyen2, N.T.T. Ha1, P.A. Duc5, D.T. Nhan1,6, N.T. Long1,6 |
| 1Project on Supporting HIV/AIDS Prevention and Control (VAAC-US.CDC Project), MoH, Ha Noi, Vietnam, 2Clinton Health Access Initiative, Ha Noi, Vietnam, 3University of Ottawa, Ottawa, Canada, 4Children’s Hospital of Eastern Ontario, Ottawa, Canada, 5Harvard Medical School AIDS Initiative, Ha Noi, Vietnam, 6Authority for HIV/AIDS Control, MoH, Ha Noi, Vietnam |
MOPE098 – Poster Exhibition |
The Cedar Project: predictors of mortality among young aboriginal people who use drugs in British Columbia, Canada |
| http://pag.aids2014.org/abstracts.aspx?aid=6188 |
| K. Jongbloed1, H. Zhang2, V. Thomas3, M. Pearce1, W.M. Christian4, M.T. Schechter1, P.M. Spittal1, for The Cedar Project Partnership |
| 1University of British Columbia, School of Population and Public Health, Vancouver, Canada, 2The Cedar Project, Vancouver, Canada, 3The Cedar Project, Prince George, Canada, 4Splatsin First Nation, Enderby, Canada |
MOPE416 – Poster Exhibition |
“It’s like there’s this glass ceiling”: Exploring the benefits and tensions of operationalizing the meaningful involvement of women living with HIV/AIDS (MIWA) in the design and delivery of HIV/AIDS services |
| http://pag.aids2014.org/abstracts.aspx?aid=9348 |
| A. Carter1,2, S. Greene3, V. Nicholson4, N. O’Brien5, M. Sanchez6, A. de Pokomandy5, M.R. Loutfy7, A. Kaida2, CHIWOS Research Team |
| 1BC Centre for Excellence in HIV/AIDS, Vancouver, Canada, 2Simon Fraser University, Burnaby, Canada, 3McMaster University, Hamilton, Canada, 4CHIWOS Study, Vancouver, Canada, 5McGill University Health Centre, Montreal, Canada, 6ViVA, Salt Spring Island, Canada, 7Women’s College Research Institute, Toronto, Canada |
MOPE418 – Poster Exhibition |
Indigenous leadership in response to HIV/AIDS: a Canadian perspective |
| http://pag.aids2014.org/abstracts.aspx?aid=10055 |
| A. King1,2, K.-S. Derejko3, E. Vides4, G. Bailey5, D. Lambert6, T. Stratton7, R. Masching7, K. Clement7 |
| 1Indigenous Physicians Association of Canada, Winnipeg, Canada, 2Simon Fraser University, Vancouver, Canada, 3Assembly of First Nations, Ottawa, Canada,4Métis National Counci, Ottawa, Canada, 5Pauktuutit Inuit Women of Canada, Ottawa, Canada, 6Kimamow Atoskanow Foundation, Onoway, Canada, 7Canadian Aboriginal AIDS Network, Vancouver, Canada |
MOPDA0105 – Poster Discussion Session |
Primary mutations that confer resistance to raltegravir and elvitegravir are incompatible with the R263K mutation that is associated with low-level resistance to dolutegravir |
| http://pag.aids2014.org/abstracts.aspx?aid=5377 |
| Presented by Mark Wainberg (Canada), K. Anstett, T. Mesplede, P. Quashie, M. Oliveira, M. Wainberg |
| McGill AIDS Centre, Lady Davis Institute, Jewish General Hospital, Montreal, Canada |
Canada Pavilion – Presentations |
10h00Imagine Men’s Health Study: Body Image, Racism, and Well-being among Gay and Bisexual Men of Colour in Toronto, Ontario, CanadaDavid J. Brennan, Factor-Inwentash Faculty of Social Work, University of Toronto |
11h30Engaging Hard-to-Reach MSM in India: Sahaay Operations Research StudyMyriam Hamdallah, FHI 360 |
16h00The Early History of the CTN’s Community Advisory Committee (CAC)Kevin Pendergraft, CIHR Canadian HIV Trials Network |
Tuesday July 22, 2014 |
TUAB0103 – Oral Abstract Session |
Switching from first antiretroviral therapy regimen while virologically suppressed is associated with increased risk of subsequent virologic failure |
| http://pag.aids2014.org/abstracts.aspx?aid=4291 |
| Presented by Marina Klein (Canada). M. Hull1,2, A. Cescon1, J. Raboud3,4, M.B. Klein5, S. Walmsley3,4, E. Ding1, S. Shurgold1, C. Tsoukas5, J.S. Montaner1,2, N. Machouf6, M.R. Loutfy4,7, C. Cooper8, A.N. Burchell4,9, R.S. Hogg1,10, CANOC Collaboration |
| 1BC Centre for Excellence in HIV/AIDS, Vancouver, Canada, 2University of British Columbia, Vancouver, Canada, 3University Health Network, Toronto, Canada, 4University of Toronto, Toronto, Canada, 5McGill University, Montreal, Canada, 6Clinique Médicale l’Actuel, Montreal, Canada, 7Women’s College Research Institute, Toronto, Canada, 8The Ottawa Hospital, Division of Infectious Diseases, Ottawa, Canada, 9Ontario HIV Treatment Network, Toronto, Canada, 10Simon Fraser University, Burnaby, Canada |
TUAB0206LB – Oral Abstract Session |
Impact of early initiation of combination antiretroviral therapy on measures of virus in peripheral blood of vertically HIV-1-infected children |
| http://pag.aids2014.org/abstracts.aspx?aid=11140 |
| Presented by Jason Brophy (Canada). J. Brophy1, T.-W. Chun2, L. Samson1, F. Kakkar3, H. Soudeyns3, M. Ostrowski4, S. Mujib5, J. Kim6, P. Sandstrom6, R. Harrigan7, S. Read8, A. Bitnun8 |
| 1Children’s Hospital of Eastern Ontario, University of Ottawa, Ottawa, Canada, 2National Institute of Allergy & Infectious Diseases, National Institutes of Health, Bethesda, United States, 3Centre Hospitalier Universitaire – Ste-Justine, Universite de Montreal, Montreal, Canada, 4University of Toronto, Department of Immunology and Medicine, Toronto, Canada, 5University of Toronto, Institute of Medical Sciences, Department of Medicine, Toronto, Canada, 6Public Health Agency of Canada, National HIV & Retrovirology Laboratories, Toronto, Canada, 7University of British Columbia, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada, 8The Hospital for Sick Children, University of Toronto, Toronto, Canada |
TUAD0302 – Oral Abstract Session |
Poverty, intersecting stigmas, and health outcomes among HIV-positive African, Caribbean and Black women in Ontario, Canada |
| http://pag.aids2014.org/abstracts.aspx?aid=2875 |
| Presented by Carmen Logie (Canada). C. Logie1, W. Tharao2, M. Loutfy3 |
| 1University of Toronto, Factor-Inwentash Faculty of Social Work, Toronto, ON, Canada, 2Women’s Health in Women’s Hands Community Health Centre, Toronto, Canada, 3Women’s College Research Institute, Toronto, Canada |
TUPE033 – Poster Exhibition |
The Impact of isoniazid preventive therapy and antiretroviral therapy on TB incidence in children living with HIV in Vietnam |
| http://pag.aids2014.org/abstracts.aspx?aid=6070 |
| K.H. Truong1, H.T. Nguyen2, X. Gao3, Y. Hu2,3, J. Harwell2,3, J. Brophy2,4 |
| 1Ho Chi Minh City Pediatric Hospital #1, Infectious Diseases, Ho Chi Minh City, Vietnam, 2Clinton Health Access Initiative, Hanoi, Vietnam, 3Chinese University of Hong Kong, Hong Kong, China, 4Children’s Hospital of Eastern Ontario, University of Ottawa, Ottawa, Canada |
TUPE078 – Poster Exhibition |
Adult and pediatric HIV care providers agree on the importance of developmental readiness in the transition of youth living with HIV from pediatric to adult care |
| http://pag.aids2014.org/abstracts.aspx?aid=9620 |
| M. Clark1, L. Samson1, J. Rusley2, J. Bowes1, J. Brophy3,4 |
| 1Children’s Hospital of Eastern Ontario, Ottawa, Canada, 2Maine Medical Center, Portland, United States, 3Children’s Hospital of Eastern Ontario, Infectious Diseases, Ottawa, Canada, 4Clinton Health Access Initiative – Vietnam, Hanoi, Vietnam |
TUPE214 – Poster Exhibition |
Place, space, and gender: Conceptualizing intersecting socio-spatial marginalities and their impacts on access to healthcare among harder-to-reach women living with HIV |
| http://pag.aids2014.org/abstracts.aspx?aid=9466 |
| A. Carter1,2, S. Greene3, V. Nicholson4, J. Dahlby1, A. de Pokomandy5, M.R. Loutfy6, A. Kadia2, CHIWOS Research Team |
| 1BC Centre for Excellence in HIV/AIDS, Vancouver, Canada, 2Simon Fraser University, Burnaby, Canada, 3McMaster University, Hamilton, Canada,4CHIWOS Study, Vancouver, Canada, 5McGill University Health Centre, Montreal, Canada, 6Women’s College Research Institute, Toronto, Canada |
TUPE315 – Poster Exhibition |
Sexual transmission of HIV in the context of the criminal law: a Canadian consensus statement |
| http://pag.aids2014.org/abstracts.aspx?aid=6130 |
| M. Tyndall1, M. Loufty2, J.-G. Baril3, J. Montaner4, R. Kaul2, C. Hankins5 |
| 1University of Ottawa, Ottawa, Canada, 2University of Toronto, Toronto, Canada, 3University of Montreal, Montreal, Canada, 4BC Centre for Excellence in HIV/AIDS, Vancouver, Canada, 5Amsterdam Institute for Global Health, Amsterdam, Netherlands |
Canada Pavilion – Presentations |
10h00Canadian HIV Vaccine Initiative: Supporting HIV Vaccine Development in CanadaDeborah Douglas, Organization – Canadian HIV Vaccine Initiative Research and Development Alliance Coordinating Office (ACO) |
11h30Canadian Contribution on HIV Persistence: To flag infected CD4 cells to develop an intelligent targeted therapyDr. Jean-Pierre Routy, McGill University, Montreal |
13h00Enabling Access to High Quality PMTCT Services by Community and Facility Strengthening in Mashonaland Central Province, ZimbabweRavikanthi Rapiti, Population Council |
14h30Canadian Contribution on HIV Persistence: To flag infected CD4 cells to develop an intelligent targeted therapyDr. Jean-Pierre Routy, McGill University, Montreal |
16h00Retention of at-risk populations enrolled in HIV prevention programs: Lessons learned from the Arise ProgramIbou Thior, PATH |
Wednesday July 23, 2014 |
WEPE224 – Poster Exhibition |
Global and regional description of barriers to access to care in HIV-1 infected women: the ELLA study |
| http://pag.aids2014.org/abstracts.aspx?aid=9595 |
| M. Johnson1, M. Loutfy2, L. Hocqueloux3, A. Streinu-Cercel4, J. van Wyk5, M. Martinez-Tristani5 |
| 1Royal Free Hospital NHS Trust, London, United Kingdom, 2Women’s College Research Institute, Toronto, Canada, 3Centre Hospitalier Régional d’Orléans, Orléans, France, 4HIV/AIDS Academy, Bucharest, Romania, 5AbbVie, Inc., North Chicago, United States |
WEPE422 – Poster Exhibition |
The CIHR Canadian HIV Trials Network (CTN) postdoctoral fellowship awards program (PFAP): a model for training and retaining young clinical scientists |
| http://pag.aids2014.org/abstracts.aspx?aid=9571 |
| J. Sas1, S. Read2, A. Rachlis2, A. Anis1, D. Cox1, J. Singer1, K. Pendergraft1 |
| 1CIHR Canadian HIV Trials Network, Providence HealthCare/University of British Columbia, Vancouver, Canada, 2CTN Postdoctoral Adjudication Committee, Toronto, Canada |
WEPDB0103 – Poster Discussion Session |
Do single tablet regimens translate into more durable HIV treatments? Evidence from the Canadian observational cohort (CANOC) |
| http://pag.aids2014.org/abstracts.aspx?aid=5802 |
| Presented by Nima Machouf (Canada). |
| N. Machouf1, L. Szadkowski2, B. Trottier1, R. Thomas1, M. Hull3,4, A.N. Burchell5,6, C. Cooper7, R.S. Hogg4,8, M.B. Klein9, M.R. Loutfy6,10, J.S.G. Montaner3,4, C. Tsoukas9, J.M. Raboud2,6, CANOC Collaboration |
| 1Clinique Médicale l’Actuel, Recherche, Montreal, Canada, 2University Health Network, Toronto, Canada, 3University of British Columbia, Vancouver, Canada, 4BC Centre for Excellence in HIV/AIDS, Vancouver, Canada, 5Ontario HIV Treatment Network, Toronto, Canada, 6University of Toronto, Toronto, Canada, 7Ottawa Hospital, Division of Infectious Diseases, Ottawa, Canada, 8Simon Fraser University, Burnaby, Canada, 9McGill University, Montreal, Canada, 10Women’s College Research Institute, Toronto, Canada |
Canada Pavilion – Presentations |
10h00Retention of at-risk populations enrolled in HIV prevention programs: Lessons learned from the Arise ProgramIbou Thior, PATH |
11h30Breaking the Cycle: Empowering Young MothersEmily Neilson, Help Lesotho |
13h00Hiring, training, and supporting peer research associates (PRAs): Operationalizing community engagement in multi-site cohort studies by, with, and for women living with HIVAllison Carter: Affiliated Institutions: Simon Fraser University & BC Centre for Excellence in HIV |
14h30The Early History of the CTN’s Community Advisory Committee (CAC)Kevin Pendergraft, CIHR Canadian HIV Trials Network |
16h00I score: incorporating the patient perspective into the evaluation of ART therapyDr. Bertrand LEBOUCHE, Chronic Viral Illness Service, McGill University Health Centre, Montreal |
Thursday July 24, 2014 |
THPE002 – Poster Exhibition |
The immune checkpoint blockers PD-1, LAG-3 and TIGIT are biomarkers of HIV infected cells during ART and identify distinct cellular reservoirs |
| http://pag.aids2014.org/abstracts.aspx?aid=5967 |
| R. Fromentin1, W. Bakeman1, M.B. Lawani1, G. Khoury2, E. Sinclair3, F.M. Hecht3, S.G. Deeks3, S.R. Lewin2,4, J.-P. Routy5, R.P. Sekaly1, N. Chomont1 |
| 1VGTIFL, Port St Lucie, United States, 2Alfred Hospital and Monash University, Department of Infectious Diseases, Melbourne, Australia, 3UCSF, Department of Medicine, San Francisco, United States, 4Burnet Institute, Centre for Biomedical Research, Melbourne, Australia, 5McGill Health Centre, Montreal, Canada |
THPE226 – Poster Exhibition |
Working together: creating an Aboriginal HIV and AIDS strategy for Canada |
| http://pag.aids2014.org/abstracts.aspx?aid=6890 |
| M.-S. Morrison1, R. Masching2 |
| 1Canadian Aboriginal AIDS Network, Research & Policy Unit, Vancouver, Canada, 2Canadian Aboriginal AIDS Network, Vancouver, Canadaa |
Canada Pavilion – Presentations |
10h00Canadian HIV Vaccine Initiative: Supporting HIV Vaccine Development in CanadaDeborah Douglas, Organization – Canadian HIV Vaccine Initiative Research and Development Alliance Coordinating Office (ACO) |
11h30Barriers to Treatment Access in Canada: A History of CTACShane Patey, Canadian Treatment Action Council (CTAC) |
Publications |
PUB033 – Publication only |
The Cedar Project: the effects of childhood maltreatment on HIV risk among young Indigenous people who use drugs in three Canadian cities |
| http://pag.aids2014.org/abstracts.aspx?aid=10589 |
| M. Pearce1, W. Christian2, K. Jongbloed1, A. Blair1, M. Schechter1, P. Spittal1, For the Cedar Project Partnership |
| 1University of British Columbia, School of Population and Public Health, Vancouver, Canada, 2Splats’in-Secwepemc Nation, Enderby, Canada |
PUB114 – Publication only |
Understanding the meaning, availability and value of women-centred HIV care and its promise for health care delivery: a qualitative study among women living with HIV in Canada |
| http://pag.aids2014.org/abstracts.aspx?aid=8569 |
| N. O’Brien1,2, A.J. Carter3,4, J. Lewis5, S. Greene6, J. Dayle1, G. Kwaramba5, S. Margolese5, B. Menard1, V.L. Nicholson3, S. Smith5, A. Kaida3, A. de Pokomandy1, M.L. Loutfy5, CHIWOS Research Team |
| 1McGill University Health Centre, Chronic Viral Illness Service, Montreal, Canada, 2Universite de Montreal, Ecole de Sante Publique, Montreal, Canada, 3Simon Fraser University, Faculty of Health Sciences, Burnaby, Canada, 4British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada, 5Women’s College Research Institute, Women’s College Hospital, University of Toronto, Toronto, Canada, 6McMaster University, Faculty of Social Work, Hamilton, Canada |
